The personalized medicine movement has begun to embrace hydroxychloroquine sulfate 200mg as a case study in tailoring treatments to individual genetic profiles. By identifying biomarkers that predict response or risk of side effects, researchers aim to optimize its use, ensuring that patients receive the most effective and safe therapy possible.